March 5, 2013
by admin
11 Comments
As President Obama signs the sequester cuts into the budget, amid dire predictions of global economic melt-down and howls of protest at the impending reduction of the science budget, there is at least one UK scientist who wishes the same … Continue reading
October 2, 2012
by admin
0 comments
There was something quite ironic when Luke Timmerman of Xconomy described DrugBaron as “Twitter-savvy”. Even allowing for poetic license that represents a turnaround to match the heroics of the European Ryder Cup golf team last weekend. When it comes to … Continue reading
September 24, 2012
by admin
5 Comments
The pharma industry, with decadal time lines and multi-billion dollar R&D budgets, is particularly sensitive to progressing projects that should have been killed. Occasionally failure is perfectly obvious, and the decision to kill a project is trivial. But much more … Continue reading